Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Tirzepatide was the first dual GLP-1/GIP agonist to reach approval, and the published SURMOUNT-1 trial showed that adding GIP to GLP-1 produces additive metabolic effects
The extract has demonstrated both anti-adipogenic (preventing fat cell formation) and antioxidant effects during the differentiation of fat cells
Clin Cancer Investig J
Clearly, there has been a need for a new class of antidiabetic agents with advantages over currently marketed drugs that can lower glucose via mechanisms resulting in either neutral or protective effects on the cardiovascular system
His bloodwork, when he had it checked at his annual physical, came back broadly clean
Evidence in this area is growing but not as robust as for skin applications
